Use App
Trending
News
Earnings
All
DIA
0.52%
SPY
0.14%
QQQ
0.11%
Trending
BB.TSX
3.95%
RENDER
11.73%
MARS
7.94%
ROBO
3.32%
DOGE
1.05%
NONJA
2.34%
DOG
0.08%
NEAR
7.12%
IMAX
16.96%
XLI
0.72%
BB.TSX
3.95%
RENDER
11.73%
MARS
7.94%
ROBO
3.32%
DOGE
1.05%
NONJA
2.34%
DOG
0.08%
NEAR
7.12%
IMAX
16.96%
XLI
0.72%
home
Symbol
RNAZ
RNAZ
TransCode Therapeutics Inc
7,271
Mkt Cap
$5.93M
Volume
7,730.00
52W High
$20.99
52W Low
$5.56
PE Ratio
-0.13
RNAZ Fundamentals
Price
$6.24
Prev Close
$6.12
Open
$6.04
50D MA
$8.18
Beta
1.99
Avg. Volume
5,616.15
EPS (Annual)
-$52.59
P/B
4.57
Rev/Employee
$0.00
$128.44
PE Ratio
-0.13
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
Compact View
Full View
Mini-Chart
Sentiment
Not available
Message Volume
Not available
Poll
What will be the primary driver of the stock market move next week?
Economic data
Earnings
Geopolitical events
Fed commentary
Advertisement
|
Remove ads.
Latest RNAZ News
View
TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State University
TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028
TransCode Secures Exclusive, Worldwide, Fully Paid-Up Royalty-Free License to Develop and Commercialize a Next-Generation Oncolytic Immunotherapy Platform in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer P
Top Discussions
top
active
trending
Loading...
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile